6:09 PM
Sep 26, 2012
 |  BC Extra  |  Financial News

NuPathe to raise $28M, cut costs

NuPathe Inc. (NASDAQ:PATH) said it plans to raise $28 million in a private placement and implement cost cutting measures ahead of the Jan. 17 PDUFA date for migraine product Zelrix ( NP101), a transdermal patch delivering...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >